We focused on Vβ13 and analysed the nucleotide sequences containing the CDR3 of TCR-β. cDNAs obtained by reverse transcription-PCR (RT-PCR) of CDR3 combined with Vβ13 in CD8+ CD122+ CD49dhigh cells, CD8+ CD122+ CD49dlow cells and CD8+ CD122− cells were cloned and compared with one another. In the clones analysed to determine the nucleotide sequences in each cell population, the most common CDR3 sequences are listed in Fig. 4. There was only one CDR3 sequence that appeared twice during DNA www.selleckchem.com/products/17-AAG(Geldanamycin).html sequence analysis of CD8+ CD122− cells (Fig. 4c). In comparison with the result obtained from CD8+ CD122− cells, three

different CDR3 sequences were found twice in CD8+ CD122+ CD49dlow cells (Fig. 4b), possibly suggesting a higher frequency of expanded clones in this cell population. In contrast with the reasonably divergent CDR3 sequences in CD8+ CD122− cells, identical CDR3 sequences were Dabrafenib frequently found in CD8+ CD122+CD49dhigh cells. In particular, one CDR3 sequence (ASSYRGAEQF) was found five times in the first experiment and six times in the second independent experiment, which suggests the expansion of T cells possessing one characteristic TCR β-chain (Fig. 4a). Exp. 1 and Exp. 2 in Figure 4 were totally independent experiments started from different mice, from which we obtained four common sequences. This result confirms that such cloning of

identical TCRs from different mice is the reflection of universal events occurring in every ADAM7 mouse, not the accidental events that occurred in some cloning step. These CDR3 sequence data are consistent with the data from the immunoscope analysis. The most frequent sequence observed in CD8+ CD122+ CD49dhigh cells (ASSYRGAEQF) and possibly by addition of sequences with the same length (e.g. ASSFRNTEVF) corresponded to the highest peak in the immunoscope analysis of Vβ13 left side peak of the red line in Fig. 3a), which was not observed in CD8+ CD122+ CD49dlow cells and CD8+ CD122− cells. We further analysed cDNA obtained from CD8+ CD122− cells, CD8+ CD122+ CD49dhigh cells, CD8+ CD122+CD49dlow

cells by immunoscope using primers for TCR Jβ combined with Vβ13, and some Vαs combined with Cα. The results of Vβ13-Jβ and Vα-Cα are shown in the Supplementary material, Fig. S1a and S1b, respectively. Although, the immunoscopic analysis using Jβ primers showed some skewed peaks as expected, it gave no further information than the analysis by Vβs-Cβ There was no clonal or oligoclonal enrichment of specific amplification of TCR clones, which would attract our attention to go into further analysis. By the analysis of α-chain by immunoscope of 11 different Vαs, we have not found any remarkable skewing of peaks in CD8+ CD122+ CD49dhigh cells or CD8+ CD122+ CD49dlow cells. We only analysed 11 different Vαs to represent all the Vαs, which are estimated to be around 100.